Bone Marrow Microenvironment Interplay and Current Clinical Practice in Multiple Myeloma: A Review of the Balkan Myeloma Study Group
The course of multiple myeloma (MM) is influenced by a variety of factors, including the specificity of the tumour microenvironment (TME). The aim of this review is to provide insight into the interplay of treatment modalities used in the current clinical practice and TME. Bortezomib-based triplets...
Main Authors: | Jelena Bila, Eirini Katodritou, Margarita Guenova, Sandra Basic-Kinda, Daniel Coriu, Milena Dapcevic, Lejla Ibricevic-Balic, Arben Ivanaj, Oliver Karanfilski, Samo Zver, Meral Beksac, Evangelos Terpos, Meletios Athanassios Dimopoulos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/17/3940 |
Similar Items
-
P981: DISEASE CHARACTERISTICS AND TREATMENT OUTCOMES OF MYELOMA PATIENTS <50 YEARS OF AGE: AN ANALYSIS OF THE BALKAN MYELOMA STUDY GROUP
by: Efstathios Kastritis, et al.
Published: (2023-08-01) -
P956: VALIDATION OF THE SECOND REVISION OF THE INTERNATIONAL STAGING SYSTEM (R2-ISS) FOR OVERALL SURVIVAL IN MULTIPLE MYELOMA IN A REAL WORLD COHORT: AN ANALYSIS BY THE BALKAN MYELOMA STUDY GROUP (BMSG)
by: Efstathios Kastritis, et al.
Published: (2023-08-01) -
The Combination of Panobinostat and Melphalan for the Treatment of Patients with Multiple Myeloma
by: Maria Gkotzamanidou, et al.
Published: (2022-12-01) -
Slovenian Guidelines for the Management of Multiple Myeloma 2015
by: Samo Zver, et al.
Published: (2015-06-01) -
Pomalidomide- and dexamethasone-based regimens in the treatment of refractory/relapsed multiple myeloma
by: Despina Fotiou, et al.
Published: (2022-05-01)